Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

CNS lymphoma and T cell lymphoma
Dr Diva Baggio, University College London Hospitals

Advances in CLL – Post EHA updates
Dr Satyen Gohil, University College London Hospitals

Hodgkin lymphoma
Professor Graham Collins, Oxford University Hospitals

CAR T and bispecifics – patient pathways
Dr David Lewis, University Hospitals Plymouth

MCL and other non-follicular indolent lymphomas
Dr Toby Eyre, Oxford University Hospitals

Follicular lymphoma
Dr William Townsend, University College London Hospitals

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Updates on newly diagnosed treatment approaches including risk/MRD stratification
Professor Martin Kaiser, Royal Marsden Hospital

Bispecific and CAR-T therapy for RRMM
Dr Jaimal Kothari, Oxford University Hospitals

Mastocytosis
Dr Deepti Radia, Guy’s and St Thomas’ NHS FT

MPN – highlights from EHA
Professor Claire Harrison, Guy’s and St Thomas’ NHS FT

CMML and related MDS/MPN overlap syndromes
Dr Daniel Wiseman, The Christie NHS Foundation Trust

Adult ALL – latest news
Dr Anna Castleton, The Christie NHS Foundation Trust

ALL CAR T patient pathway
Dr Claire Roddie, University College London Hospitals

Comprehensive management of FLT3 positive AML in 2026
Dr Pramila Krishnamurthy, King’s College Hospital

What’s new in AML from EHA?
Dr Jenny O’Nions, University College London Hospitals

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Pathogenesis of ITP
Professor Nichola Cooper, London

ITP epidemiology: what have we learnt this last decade?
Professor Guillaume Moulis, Toulouse

Artificial intelligence & machine learning for diagnosis & management of ITP
Dr Drew Provan, London

Update on the use of guidelines and the need for standard definitions in ITP
Professor Cindy Neunert, New York

Thrombosis in ITP
Dr Charlotte Bradbury, Bristol

Using combination treatment in refractory disease
Dr Lucy Kamuriwo, London

Working with the psychological challenges of ITP
Dr Andrew Morgan, Psychologist, Liverpool

Fatigue in ITP, how prevalent is it and how can we manage it?
Dr Alice Hart, London

How to get involved in clinical research
Camelia Vladescu, London

Understanding the genetic basis of autoimmune cytopenias
Dr Nehal Joshi, London

Updates in FNAIT
Dr Mike Desborough, Oxford

The latest updates for ITP and AIHA treatments
Professor David Kuter, Boston

The future of autoimmune cytopenias – moving towards a cure
Professor Nichola Cooper, London

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

The role of the microbiome in the prevention and treatment of acute GVHD
Dr Florent Malad, St Antoine Hospital, Paris

Lung GVHD – the unmet need and EBMT guidance
Dr Saskia Bos, University Hospitals Leuven

Quality of life in chronic GVHD and how it can be improved
Dr Zinaida Perić, Clinical Hospital Centre Rijeka, Croatia

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Acute + chronic GVHD cases – adults
Dr Harpreet Kaur, Sheffield Teaching Hospitals 

Acute + chronic GVHD cases – paediatric
Dr Sarah Lawson, Birmingham Children’s Hospital 

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Allo-SCT for SCD and TDT
Dr Ben Carpenter, University College London Hospitals

PNH treatment or transplant
Dr Austin Kulasekararaj, King’s College Hospital

Axatilimab and new CSFR targeting therapies
Professor Daniel Wolff, University Hospital Regensburg, Germany

Combination therapy and ECP
Professor Nicolaus Kröger, University Hospital Essen, Germany

Panel discussion: Perspectives on treatments and new options
Led by Dr Emma Kempshall, Cardiff and Vale University Health Board

Complications of transplant
Dr Varun Mehra, King’s College Hospital 

Quality of life and long term complications
Professor John Murray The Christie, Manchester and Joanne Stobart, Patient

The impact that CAR T has had on transplant
Julia Lee, Head of BSBMTCT Data Registry

RWE for lymphoma and MCL
Dr Robin Sanderson, King’s College Hospital

CAR T and options in RR myeloma
Dr Jaimal Kothari, Oxford University Hospitals

Registration is free of charge

Monoclonal gammopathy of thrombotic significance (MGTS)
Dr Will Lester, Haematology Consultant, University Hospital of Birmingham, Queen Elizabeth and Birmingham Women’s Hospital

Antiphospholipid syndrome and thrombocytopenia – clinical significance and treatment
Prof Jecko Thachil, Consultant in Haemostasis and Thrombosis, Manchester Royal Infirmary

Antiphospholipid syndrome testing on anticoagulants – what’s new?
Dr Steve Kitchen, Lead Clinical Scientist, Dept of Coagulation, Sheffield Haemophilia and Thrombosis Centre

Autoimmune haemolytic anaemia – an update
Dr Gary Benson, Clinical Director, Northern Ireland Haemophilia Centre

An educational resource from Grifols

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Introduction on NCRI MPN group and future plans
Dr Donal McLornan, UCLH & Professor Beth Psaila, University of Oxford

Essential thrombocythemia
Dr Andrew McGregor, Newcastle upon Tyne Hospitals

CML
Dr Ali Mahdi, Aneurin Bevan University Health Board

Polycythemia vera
Dr Fran Wadelin, Nottingham University Hospitals

Myelofibrosis
Professor Tim Somervaille, The Christie NHS Foundation Trust

CALR therapies
Professor Beth Psaila, University of Oxford

BMT
Dr Donal McLornan, University College London Hospital

Placement of JAKi
Dr Jen O’Sullivan, Guy’s and St Thomas’ NHS FT

Tricky case discussion with morphology MDS/MPN
Dr Alesia Khan, Leeds Teaching Hospitals

Updates in thrombocytosis: classification and management
Dr Anna Godfrey, Cambridge University Hospitals

Pregnancy updates
Dr Susan Robinson, Guy’s and St Thomas’ NHS Foundation Trust

Lessons learnt from PT1
Professor Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust
Dr William Dunn, Cambridge University Hospitals

Case studies: anticoagulation and MPN
Dr Susie Shapiro, Oxford University Hospitals

Cardiovascular risk stratification of MPN – what’s new?
Dr Patrick Harrington, Guy’s and St Thomas’ Hospital

Making the best of your EHR and navigating AI
Dr Wai Keong Wong, Cambridge University Hospitals

How should we be managing PV in 2025 and what should we do in the future
Professor Adam Mead, Oxford University Hospitals

How to manage indolent SM
Dr Jon Lambert, University College London Hospitals

Perspectives on use of interferon in MPN
Professor Reuben Mesa, Atrium Health Levine Cancer Institute, North Carolina

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

UK trials in fit adults
Professor Steve Knapper, Cardiff

EVOLVE trial portfolio in unfit adults
Dr Mike Dennis, Manchester

UK AML transplant and cell therapy trials
Dr Victoria Potter, London

Relapsed AML – current and future treatment opportunities
Dr John Chadwick, Manchester

Strategy to improve equity of outcomes in AML
Dr Pramila Krishnamurthy, London

Supportive care trials
Dr Justin Loke, Birmingham and Dr Anjum Khan, Leeds

MyeCare the UK AML registry
Dr Priyanka Mehta, and Dr Katy Fleming, Bristol

Evolving treatment algorithms in AML
Dr Tom Coats, Exeter

Accelerating haemato-oncology trial delivery in the UK
Professor Charles Craddock, Birmingham

David Grimwade Lecture: Optimising outcomes in fit adults with AML
Professor Gail Roboz, New York Presbyterian Hospital

Allogeneic stem cell transplant: who and how
Professor Michael Heuser, University Hospital Halle

New approaches to MRD: Insights into mechanisms of resistance and implications for future treatment trial design
Professor Paresh Vyas, University of Oxford

Management of AML in pregnancy
Professor David Allsup, Hull

Optimising outcomes in APML
Professor Steve Knapper, Cardiff

AML in the TYA population
Dr Gillian Horne, Glasgow

Past, present and future of AML therapy
Professor Nigel Russell, London

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

CLL overview
Dr Niamh Appleby, Dublin 

Update on clinical trials & managing side effects
Dr Satyen Gohil & Rafaela Machado, UCLH

Staying compassionate, staying boundaried – for patients and ourselves
Sarah Noakes, St George’s Hospital, London

CLL treatment from a pharmacist’s perspective
Wen Yuen Lim, Oxford 

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

CAR-T in renal disease – outcomes and complications
Dr Ruth Pepper, Consultant Nephrologist, Royal Free London / UCLH 

Fertility considerations
Professor Melanie Davies, Consultant Gynaecologist, University College London Hospitals 

Secondary cancers
Dr Claire Roddie, University College London 

Roundtable discussion: how to set-up a service
Led by Dr Claire Roddie
Panel: Dr Maria Leandro, Dr Ruth Pepper, Prof Melanie Davies, Dr Eleni Tholouli, Dr Frederick Vonberg, Maia Collins 

Registration is free of charge

Hartley Taylor meetings receive financial support with a sponsorship arrangement from our multiple industry partners

Clinical trials – due to open and recruiting – PV, ET, MF
Dr Donal McLornan, Consultant Haematologist, University College London Hospitals

Inequality of services – how can everyone benefit from AI
Dr Majid Kazmi, Chief Medical Officer, Pharos AI 

Interferon switches: dosing, deviations & global supply challenges in practice
Llwelyn Cadman Davies, Lead Pharmacist, GSTT
Claire Woodley, Advanced Nurse Practitioner, GSTT

Menopause, HRT and MPNs – thrombosis risk
Dr Priya Sriskandarajah, Consultant Haematologist, Guy’s and St Thomas’ NHS FT

BSH/ELN Guidelines for CML – Sequencing of treatment
Dr Dragana Milojkovic, Consultant Haematologist, Imperial College Healthcare

AHP-led clinics in CML
Kate Wood, Principal Pharmacist, Sheffield Teaching Hospitals 

Registration is free of charge